WASHINGTON — The maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market, even as health regulators insist that it doesn’t work. “Makena and its associated generics represent the only treatment currently available to obstetrician-gynecologists to help prevent this condition.” But the FDA says existing …
For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. “If we could find an intervention as simple as …